Shian‐Ying Sung

2.6k total citations
59 papers, 1.9k citations indexed

About

Shian‐Ying Sung is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shian‐Ying Sung has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shian‐Ying Sung's work include Prostate Cancer Treatment and Research (13 papers), Cancer Cells and Metastasis (7 papers) and RNA Interference and Gene Delivery (5 papers). Shian‐Ying Sung is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cancer Cells and Metastasis (7 papers) and RNA Interference and Gene Delivery (5 papers). Shian‐Ying Sung collaborates with scholars based in Taiwan, United States and Japan. Shian‐Ying Sung's co-authors include Leland W.K. Chung, Chia‐Ling Hsieh, Richard T. Marconi, Sajni Josson, Haiyen E. Zhau, Peter A.S. Johnstone, Jason A. Carlyon, Kaiqin Lao, Katsumi Shigemura and Magnus Edlund and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Shian‐Ying Sung

56 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shian‐Ying Sung 911 581 528 379 187 59 1.9k
François Plénat 665 0.7× 260 0.4× 347 0.7× 333 0.9× 92 0.5× 95 2.0k
Audrey Brenot 1.1k 1.2× 474 0.8× 937 1.8× 195 0.5× 108 0.6× 25 2.5k
Patricia Chévez‐Barrios 737 0.8× 182 0.3× 582 1.1× 303 0.8× 116 0.6× 144 2.8k
Christina Mertens 863 0.9× 207 0.4× 280 0.5× 304 0.8× 104 0.6× 41 2.1k
Sandra K. Cooper 540 0.6× 191 0.3× 253 0.5× 167 0.4× 219 1.2× 21 1.8k
Zhiming Mai 437 0.5× 166 0.3× 318 0.6× 645 1.7× 156 0.8× 42 1.8k
Robert K. Bright 670 0.7× 202 0.3× 477 0.9× 316 0.8× 53 0.3× 60 1.5k
Elisabeth Naschberger 1.3k 1.4× 300 0.5× 825 1.6× 264 0.7× 58 0.3× 90 3.2k
Ricardo J. Giordano 1.2k 1.3× 270 0.5× 530 1.0× 134 0.4× 39 0.2× 51 2.1k
David A. Lucas 1.4k 1.5× 153 0.3× 179 0.3× 75 0.2× 120 0.6× 35 2.2k

Countries citing papers authored by Shian‐Ying Sung

Since Specialization
Citations

This map shows the geographic impact of Shian‐Ying Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shian‐Ying Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shian‐Ying Sung more than expected).

Fields of papers citing papers by Shian‐Ying Sung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shian‐Ying Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shian‐Ying Sung. The network helps show where Shian‐Ying Sung may publish in the future.

Co-authorship network of co-authors of Shian‐Ying Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Shian‐Ying Sung. A scholar is included among the top collaborators of Shian‐Ying Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shian‐Ying Sung. Shian‐Ying Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Elaine, et al.. (2025). Case Report: An endogenous endophthalmitis case caused by Haemophilus influenzae. Frontiers in Medicine. 12. 1692870–1692870.
2.
Arbiser, Jack L., et al.. (2024). Dibenzolium induces apoptosis and inhibits epithelial-mesenchymal transition (EMT) in bladder cancer cell lines. Scientific Reports. 14(1). 25501–25501. 1 indexed citations
3.
Wu, Kuo-Sheng, Wei-Chung Allen Lee, Yu‐Ling Lin, et al.. (2024). RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor. Neoplasia. 58. 101075–101075. 1 indexed citations
4.
Hsieh, Chia‐Ling, et al.. (2024). L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells. The Prostate. 84(16). 1434–1447. 2 indexed citations
5.
Wu, Kuo-Sheng, Shian‐Ying Sung, Yu‐Ling Lin, et al.. (2022). Clinical and Molecular Features in Medulloblastomas Subtypes in Children in a Cohort in Taiwan. Cancers. 14(21). 5419–5419. 3 indexed citations
7.
Huang, Shenq‐Shyang, et al.. (2021). A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells. Frontiers in Oncology. 11. 638311–638311. 6 indexed citations
8.
Chen, Bo-Wei, et al.. (2020). Synthesis and characterization of magnetic nanoparticles coated with polystyrene sulfonic acid for biomedical applications. Science and Technology of Advanced Materials. 21(1). 471–481. 33 indexed citations
9.
Sung, Shian‐Ying, et al.. (2020). Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan. PLoS ONE. 15(11). e0242429–e0242429. 3 indexed citations
10.
Ishii, Aya, Katsumi Shigemura, Koichi Kitagawa, et al.. (2020). Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer. Anticancer Research. 40(9). 5107–5114. 13 indexed citations
11.
Hsieh, Chia‐Ling, et al.. (2019). A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway. Molecular Cancer Therapeutics. 19(1). 101–111. 24 indexed citations
12.
Yang, Shun‐Tai, Katsumi Shigemura, Koichi Kitagawa, et al.. (2017). Reactive oxygen species–mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression. Scientific Reports. 7(1). 9065–9065. 24 indexed citations
14.
Sung, Shian‐Ying, Junn-Liang Chang, Kuan‐Chou Chen, et al.. (2016). Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter–Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth. PLoS ONE. 11(4). e0153350–e0153350. 11 indexed citations
15.
Lin, Chen-Yuan, Hung‐Jen Chen, Liang‐Chuan Lai, et al.. (2014). ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway. Cancer Research. 74(18). 5229–5243. 69 indexed citations
16.
Josson, Sajni, Shian‐Ying Sung, Peter A.S. Johnstone, et al.. (2010). Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. The Prostate. 71(3). 232–240. 42 indexed citations
17.
Johnson, Nicole, et al.. (2010). A novel targeting modality for renal cell carcinoma: human osteocalcin promoter‐mediated gene therapy synergistically induced by vitamin C and vitamin D3. The Journal of Gene Medicine. 12(11). 892–903. 11 indexed citations
18.
Sung, Shian‐Ying, Chia‐Ling Hsieh, Andrew M. K. Law, et al.. (2008). Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis. Cancer Research. 68(23). 9996–10003. 124 indexed citations
19.
Sung, Shian‐Ying, Chia‐Ling Hsieh, Daqing Wu, Leland W.K. Chung, & Peter A.S. Johnstone. (2007). Tumor Microenvironment Promotes Cancer Progression, Metastasis, and Therapeutic Resistance. Current Problems in Cancer. 31(2). 36–100. 83 indexed citations
20.
Sung, Shian‐Ying, et al.. (1996). N-Linked Glycosylation of Hepatitis B Surface Antigens Is Involved but Not Essential in the Assembly of Hepatitis Delta Virus. Virology. 220(1). 28–36. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026